Admission Date:  [**2152-10-2**]       Discharge Date:  [**2152-10-11**]   Service:  MEDICINE ONCOLOGY  HISTORY OF PRESENT ILLNESS:  This is an 81-year-old female with a history of metastatic melanoma with known metastases to the liver and lung who status post resection in the 90s with recurrence in [**2146**] status post treatment with Taxol.
She was maintained on Nipride GTT.
In the Intensive Care Unit, the patient was weaned off Nipride and then changed to Labetalol, Hydralazine.
The patient was also noted to have cellulitis on her left knee and was initially maintained on Vancomycin and later changed to Keflex.
The patient was also evaluated by Radiation/Oncology, and it was decided that the patient would received a total of seven treatments of whole brain radiation therapy in conjunction with Decadron, as well as Dilantin.
PAST MEDICAL HISTORY:  Metastatic melanoma status post resection in [**2138**] with recurrence in [**2146**] status post treatment with Taxol.
History of paroxysmal atrial fibrillation with anticoagulation in the past.
Status post PCM for sinoatrial dysfunction.
History of coronary artery disease status post myocardial infarction in [**2143**].
Status post skin graft.
ALLERGIES:  AMOXICILLIN, OXACILLIN AND PERCOCET, REACTIONS UNKNOWN.
MEDICATIONS ON ADMISSION:  Imdur 30 mg, Warfarin, Lasix 20 q.d., Calcium Carbonate 1500 q.d., Vitamin D 4000 q.d., Colace 100 mg b.i.d., Protonix 40 q.d., Dietrol 2 mg b.i.d., Labetalol 300 mg b.i.d., Lipitor 10 mg p.o.
LABORATORY DATA:  On admission her white count was 6.4, hematocrit 37.5, platelet count 269, neutrophils 73, 22 lymphs, 3 monos; INR 1.1, PT 12.7, PTT 27.8; sodium 138, potassium 4.3, chloride 106, bicarb 22, BUN 36, creatinine 1.8, baseline 1.4-1.5; platelet count 151; calcium 10.6, magnesium 1.9, phos 3.1, CK 116, MB 5, troponin 0.04; Albumin 4.2; TSH 2.9; urinalysis with occasional bacteria, trace ketones, 30 protein.
The patient was evaluated by Radiation/Oncology, and it was decided that the patient would receive a total of seven treatments of whole-brain radiation therapy.
She tolerated her Decadron well and tolerated her whole-brain radiation therapy without any complications.
The patient was discharged on a Decadron taper.
Her Dilantin dose was increased to a total of 300 three times a day, given that her Dilantin level [**Company 2240**].i.d.
Hypertension:  The patient's blood pressures while in the Emergency Room were noted to be 200/100; however, once she was transferred to the floor, she maintained very good control on a combination of Clonidine, Hydrochlorothiazide and Minoxidil, Hydralazine, as well as Labetalol 400 b.i.d.
Cellulitis:  The patient was initially maintained on Vancomycin, and this was later changed to Keflex.
Coronary artery disease:  The patient was maintained on enteric coated Aspirin, as well as Labetalol.
FEN:  The patient was maintained on a soft diet, as well as thin liquids.
She was held off all anticoagulation given her metastatic disease to the brain.
as needed, Hydrochlorothiazide 25 mg 1 p.o.
q.d., Minoxidil 10 mg 1 tab p.o.
q.d., Hydralazine 25 mg 3 tab p.o.
q.6 hours, Clonodine 0.1 mg 1 tab p.o.
t.i.d., Aspirin 325 1 p.o.
q.d., Pantoprazole 40 mg 1 p.o.
q.d., Keflex 500 mg 1 p.o.
b.i.d., Phenytoin 300 mg 1 p.o.
t.i.d., Dexamethasone taper 8 mg p.o.
b.i.d., then Dexamethasone again 0.25 mg p.o.
for 5 days, then Dexamethasone 0.25 mg 1 p.o.
for 5 days, and then stop, Labetalol HCL 200 mg 2 tab b.i.d., Bactrim DS 1 tab p.o.
